The INTERCEPT Blood System, pathogen reduction system, inactivates a broad spectrum of viruses, gram-positive and gram-negative bacteria, spirochetes, parasites and leukocytes. INTERCEPT is intended to reduce the risk of transfusion-transmitted infection (TTI) in platelet and plasma components. T-cells are also reduced to a level that potentially lowers the risk of transfusion-associated graft-versus-host disease (TA-GVHD) in platelet components.
Why pathogen reduction?
A proactive, comprehensive solution to reducing transfusion-transmitted infectious risk.
Streamline operations while reducing the risk of Transfusion Transmitted Infections (TTI) with the INTERCEPT Blood System.